Initial Physician Experience with [(18)F]Flutemetamol Amyloid PET Imaging Following Availability for Routine Clinical Use in Japan

BACKGROUND: Brain amyloid is a neuropathological hallmark of Alzheimer’s disease (AD). By visualizing brain amyloid, positron emission tomography (PET) may influence the diagnostic assessment and management of patients with cognitive impairment. OBJECTIVE: As part of a Japanese post-approval study t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattori, Naoya, Sherwin, Paul, Farrar, Gill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369136/
https://www.ncbi.nlm.nih.gov/pubmed/32715277
http://dx.doi.org/10.3233/ADR-190150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369136/
https://www.ncbi.nlm.nih.gov/pubmed/32715277
http://dx.doi.org/10.3233/ADR-190150

Ejemplares similares